{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:25:32Z","timestamp":1793316332087,"version":"4.5.0"},"reference-count":235,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41568-026-00948-6","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:39:55Z","timestamp":1781779195000},"page":"643-660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Beyond oncogenesis: the unexplored benefits of viruses in cancer immunity"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9735-606X","authenticated-orcid":false,"given":"Xin Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5200-2372","authenticated-orcid":false,"given":"Chi-Ping","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3943-8299","authenticated-orcid":false,"given":"Eugene V.","family":"Koonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"948_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang, J. D. et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat. Rev. Gastroenterol. Hepatol. 16, 589\u2013604 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"948_CR2","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41571-024-00904-z","volume":"21","author":"T Malagon","year":"2024","unstructured":"Malagon, T., Franco, E. L., Tejada, R. & Vaccarella, S. Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination. Nat. Rev. Clin. Oncol. 21, 522\u2013538 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"948_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrc.2016.92","volume":"16","author":"LS Young","year":"2016","unstructured":"Young, L. S., Yap, L. F. & Murray, P. G. Epstein\u2013Barr virus: more than 50 years old and still providing surprises. Nat. Rev. Cancer 16, 789\u2013802 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"948_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.77","volume":"3","author":"JC Becker","year":"2017","unstructured":"Becker, J. C. et al. Merkel cell carcinoma. Nat. Rev. Dis. Primers 3, 17077 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"948_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrc2111","volume":"7","author":"M Matsuoka","year":"2007","unstructured":"Matsuoka, M. & Jeang, K. T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer 7, 270\u2013280 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"948_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrc2888","volume":"10","author":"EA Mesri","year":"2010","unstructured":"Mesri, E. A., Cesarman, E. & Boshoff, C. Kaposi\u2019s sarcoma and its associated herpesvirus. Nat. Rev. Cancer 10, 707\u2013719 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"948_CR7","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/nrc2961","volume":"10","author":"PS Moore","year":"2010","unstructured":"Moore, P. S. & Chang, Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat. Rev. Cancer 10, 878\u2013889 (2010). A landmark synthesis tracing the history of tumour virology research from early animal models to validated human oncogenic viruses, essential for understanding how the concept developed historically.","journal-title":"Nat. Rev. Cancer"},{"key":"948_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/emph\/eov003","volume":"2015","author":"IG Bravo","year":"2015","unstructured":"Bravo, I. G. & Felez-Sanchez, M. Papillomaviruses: viral evolution, cancer and evolutionary medicine. Evol. Med. Public Health 2015, 32\u201351 (2015). This study provides a framework to understand viral evolution using HPVs as examples.","journal-title":"Evol. Med. Public Health"},{"key":"948_CR9","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1002\/ijc.22089","volume":"119","author":"GH Ashrafi","year":"2006","unstructured":"Ashrafi, G. H., Haghshenas, M., Marchetti, B. & Campo, M. S. E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Int. J. Cancer 119, 2105\u20132112 (2006).","journal-title":"Int. J. Cancer"},{"key":"948_CR10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1365-2567.2010.03255.x","volume":"129","author":"JS Yi","year":"2010","unstructured":"Yi, J. S., Cox, M. A. & Zajac, A. J. T-cell exhaustion: characteristics, causes and conversion. Immunology 129, 474\u2013481 (2010).","journal-title":"Immunology"},{"key":"948_CR11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/349612a0","volume":"349","author":"CD Gregory","year":"1991","unstructured":"Gregory, C. D. et al. Activation of Epstein\u2013Barr virus latent genes protects human B cells from death by apoptosis. Nature 349, 612\u2013614 (1991).","journal-title":"Nature"},{"key":"948_CR12","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1002\/ijc.21731","volume":"118","author":"DM Parkin","year":"2006","unstructured":"Parkin, D. M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118, 3030\u20133044 (2006).","journal-title":"Int. J. Cancer"},{"key":"948_CR13","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","volume":"4","author":"M Plummer","year":"2016","unstructured":"Plummer, M. et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob. Health 4, e609\u2013e616 (2016).","journal-title":"Lancet Glob. Health"},{"key":"948_CR14","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","volume":"8","author":"C de Martel","year":"2020","unstructured":"de Martel, C., Georges, D., Bray, F., Ferlay, J. & Clifford, G. M. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob. Health 8, e180\u2013e190 (2020). Along with Parkin et al. (2006) and Plummer et al. (2016), this study is a foundational longitudinal epidemiological analysis of infection-associated cancer globally, providing a quantitative assessment of the magnitude of the problem and motivating the further study of oncogenic viruses.","journal-title":"Lancet Glob. Health"},{"key":"948_CR15","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","volume":"336","author":"MH Chang","year":"1997","unstructured":"Chang, M. H. et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan childhood hepatoma study group. N. Engl. J. Med. 336, 1855\u20131859 (1997). This study demonstrated that universal hepatitis B vaccination in Taiwan notably reduced childhood HCC incidence, providing the first proof that a viral vaccine could prevent a human cancer.","journal-title":"N. Engl. J. Med."},{"key":"948_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nri.2017.140","volume":"18","author":"OJ Finn","year":"2018","unstructured":"Finn, O. J. The dawn of vaccines for cancer prevention. Nat. Rev. Immunol. 18, 183\u2013194 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"948_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.coviro.2021.02.002","volume":"47","author":"EV Koonin","year":"2021","unstructured":"Koonin, E. V., Dolja, V. V. & Krupovic, M. The healthy human virome: from virus-host symbiosis to disease. Curr. Opin. Virol. 47, 86\u201394 (2021). This study provides a conceptual framework for understanding the healthy human virome as a dynamic ecosystem shaped by virus\u2013host symbiosis.","journal-title":"Curr. Opin. Virol."},{"key":"948_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-virology-110615-042323","volume":"4","author":"MJ Roossinck","year":"2017","unstructured":"Roossinck, M. J. & Bazan, E. R. Symbiosis: viruses as intimate partners. Annu. Rev. Virol. 4, 123\u2013139 (2017).","journal-title":"Annu. Rev. Virol."},{"key":"948_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3234-4","volume":"17","author":"C Jacqueline","year":"2017","unstructured":"Jacqueline, C. et al. Infections and cancer: the \u201cfifty shades of immunity\u201d hypothesis. BMC Cancer 17, 257 (2017).","journal-title":"BMC Cancer"},{"key":"948_CR20","doi-asserted-by":"publisher","first-page":"e8804","DOI":"10.1371\/journal.pone.0008804","volume":"5","author":"S Perry","year":"2010","unstructured":"Perry, S. et al. Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS ONE 5, e8804 (2010).","journal-title":"PLoS ONE"},{"key":"948_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jtbi.2010.11.009","volume":"270","author":"S Cobey","year":"2011","unstructured":"Cobey, S. & Pascual, M. Consequences of host heterogeneity, epitope immunodominance, and immune breadth for strain competition. J. Theor. Biol. 270, 80\u201387 (2011).","journal-title":"J. Theor. Biol."},{"key":"948_CR22","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.cell.2006.01.034","volume":"124","author":"BB Finlay","year":"2006","unstructured":"Finlay, B. B. & McFadden, G. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124, 767\u2013782 (2006).","journal-title":"Cell"},{"key":"948_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","volume":"19","author":"RS Fujinami","year":"2006","unstructured":"Fujinami, R. S., von Herrath, M. G., Christen, U. & Whitton, J. L. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin. Microbiol. Rev. 19, 80\u201394 (2006).","journal-title":"Clin. Microbiol. Rev."},{"key":"948_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/diseases13060181","volume":"13","author":"M Jankovic","year":"2025","unstructured":"Jankovic, M. et al. A potential oncoprotective role of cytomegalovirus against breast cancer: worldwide correlation and survey of evidence. Diseases 13, 181 (2025).","journal-title":"Diseases"},{"key":"948_CR25","doi-asserted-by":"publisher","first-page":"e01111","DOI":"10.1002\/cti2.1111","volume":"9","author":"Q Leng","year":"2020","unstructured":"Leng, Q., Tarbe, M., Long, Q. & Wang, F. Pre-existing heterologous T-cell immunity and neoantigen immunogenicity. Clin. Transl. Immunol. 9, e01111 (2020).","journal-title":"Clin. Transl. Immunol."},{"key":"948_CR26","doi-asserted-by":"publisher","first-page":"102171","DOI":"10.1016\/j.coi.2022.102171","volume":"75","author":"L Zitvogel","year":"2022","unstructured":"Zitvogel, L. & Kroemer, G. Cross-reactivity between microbial and tumor antigens. Curr. Opin. Immunol. 75, 102171 (2022).","journal-title":"Curr. Opin. Immunol."},{"key":"948_CR27","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/cam4.682","volume":"5","author":"ES Amirian","year":"2016","unstructured":"Amirian, E. S. et al. History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC). Cancer Med. 5, 1352\u20131358 (2016).","journal-title":"Cancer Med."},{"key":"948_CR28","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/aje\/kwi119","volume":"161","author":"M Wrensch","year":"2005","unstructured":"Wrensch, M. et al. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls. Am. J. Epidemiol. 161, 929\u2013938 (2005).","journal-title":"Am. J. Epidemiol."},{"key":"948_CR29","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s10552-010-9546-1","volume":"21","author":"DW Cramer","year":"2010","unstructured":"Cramer, D. W. et al. Mumps and ovarian cancer: modern interpretation of an historic association. Cancer Causes Control. 21, 1193\u20131201 (2010).","journal-title":"Cancer Causes Control."},{"key":"948_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.hoc.2011.10.009","volume":"26","author":"DW Cramer","year":"2012","unstructured":"Cramer, D. W. The epidemiology of endometrial and ovarian cancer. Hematol. Oncol. Clin. North Am. 26, 1\u201312 (2012).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"948_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jns.2015.06.033","volume":"356","author":"PW O\u2019Malley","year":"2015","unstructured":"O\u2019Malley, P. W., Mulla, Z. D. & Nesic, O. Multiple sclerosis and breast cancer. J. Neurol. Sci. 356, 137\u2013141 (2015).","journal-title":"J. Neurol. Sci."},{"key":"948_CR32","doi-asserted-by":"publisher","first-page":"16955","DOI":"10.1073\/pnas.1902623116","volume":"116","author":"K Tengvall","year":"2019","unstructured":"Tengvall, K. et al. Molecular mimicry between anoctamin 2 and Epstein\u2013Barr virus nuclear antigen 1 associates with multiple sclerosis risk. Proc. Natl Acad. Sci. USA 116, 16955\u201316960 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"948_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2001-2-6-reviews1017","volume":"2","author":"DJ Griffiths","year":"2001","unstructured":"Griffiths, D. J. Endogenous retroviruses in the human genome sequence. Genome Biol. 2, reviews1017.1\u2013reviews1017.5 (2001).","journal-title":"Genome Biol."},{"key":"948_CR34","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.tim.2023.09.006","volume":"32","author":"J Wang","year":"2024","unstructured":"Wang, J., Lu, X., Zhang, W. & Liu, G. H. Endogenous retroviruses in development and health. Trends Microbiol. 32, 342\u2013354 (2024).","journal-title":"Trends Microbiol."},{"key":"948_CR35","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1007\/s00018-015-1947-6","volume":"72","author":"M Suntsova","year":"2015","unstructured":"Suntsova, M. et al. Molecular functions of human endogenous retroviruses in health and disease. Cell Mol. Life Sci. 72, 3653\u20133675 (2015).","journal-title":"Cell Mol. Life Sci."},{"key":"948_CR36","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nrmicro1163","volume":"3","author":"RA Edwards","year":"2005","unstructured":"Edwards, R. A. & Rohwer, F. Viral metagenomics. Nat. Rev. Microbiol. 3, 504\u2013510 (2005).","journal-title":"Nat. Rev. Microbiol."},{"key":"948_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cell.2014.02.032","volume":"157","author":"HW Virgin","year":"2014","unstructured":"Virgin, H. W. The virome in mammalian physiology and disease. Cell 157, 142\u2013150 (2014).","journal-title":"Cell"},{"key":"948_CR38","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.chom.2020.08.003","volume":"28","author":"AC Gregory","year":"2020","unstructured":"Gregory, A. C. et al. The gut virome database reveals age-dependent patterns of virome diversity in the human gut. Cell Host Microbe 28, 724\u2013740 e728 (2020).","journal-title":"Cell Host Microbe"},{"key":"948_CR39","doi-asserted-by":"publisher","first-page":"104418","DOI":"10.1016\/j.isci.2022.104418","volume":"25","author":"S Li","year":"2022","unstructured":"Li, S. et al. A catalog of 48,425 nonredundant viruses from oral metagenomes expands the horizon of the human oral virome. iScience 25, 104418 (2022).","journal-title":"iScience"},{"key":"948_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10294-x","volume":"10","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Altered respiratory virome and serum cytokine profile associated with recurrent respiratory tract infections in children. Nat. Commun. 10, 2288 (2019).","journal-title":"Nat. Commun."},{"key":"948_CR41","doi-asserted-by":"publisher","first-page":"199004","DOI":"10.1016\/j.virusres.2022.199004","volume":"323","author":"B Feng","year":"2023","unstructured":"Feng, B. et al. An atlas of the blood virome in healthy individuals. Virus Res. 323, 199004 (2023).","journal-title":"Virus Res."},{"key":"948_CR42","doi-asserted-by":"publisher","first-page":"e0117825","DOI":"10.1128\/spectrum.01178-25","volume":"13","author":"Z Li","year":"2025","unstructured":"Li, Z. et al. A comprehensive reference catalog of human skin DNA virome reveals novel viral diversity and microenvironmental influences. Microbiol. Spectr. 13, e0117825 (2025).","journal-title":"Microbiol. Spectr."},{"key":"948_CR43","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1099\/jgv.0.001097","volume":"99","author":"A Garretto","year":"2018","unstructured":"Garretto, A., Thomas-White, K., Wolfe, A. J. & Putonti, C. Detecting viral genomes in the female urinary microbiome. J. Gen. Virol. 99, 1141\u20131146 (2018).","journal-title":"J. Gen. Virol."},{"key":"948_CR44","doi-asserted-by":"publisher","first-page":"e0299891","DOI":"10.1371\/journal.pone.0299891","volume":"19","author":"X Dang","year":"2024","unstructured":"Dang, X. et al. Characterization of the brain virome in human immunodeficiency virus infection and substance use disorder. PLoS ONE 19, e0299891 (2024).","journal-title":"PLoS ONE"},{"key":"948_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00284-023-03537-0","volume":"81","author":"T Bhagchandani","year":"2023","unstructured":"Bhagchandani, T., Nikita, Verma, A. & Tandon, R. Exploring the human virome: composition, dynamics, and implications for health and disease. Curr. Microbiol. 81, 16 (2023).","journal-title":"Curr. Microbiol."},{"key":"948_CR46","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41586-025-09786-2","volume":"649","author":"J Wirbel","year":"2026","unstructured":"Wirbel, J. et al. Long-read metagenomics reveals phage dynamics in the human gut microbiome. Nature 649, 982\u2013990 (2026).","journal-title":"Nature"},{"key":"948_CR47","doi-asserted-by":"publisher","first-page":"goac012","DOI":"10.1093\/gastro\/goac012","volume":"10","author":"T Borodovich","year":"2022","unstructured":"Borodovich, T., Shkoporov, A. N., Ross, R. P. & Hill, C. Phage-mediated horizontal gene transfer and its implications for the human gut microbiome. Gastroenterol. Rep. 10, goac012 (2022).","journal-title":"Gastroenterol. Rep."},{"key":"948_CR48","doi-asserted-by":"publisher","first-page":"20236","DOI":"10.1073\/pnas.1319470110","volume":"110","author":"A Reyes","year":"2013","unstructured":"Reyes, A., Wu, M., McNulty, N. P., Rohwer, F. L. & Gordon, J. I. Gnotobiotic mouse model of phage-bacterial host dynamics in the human gut. Proc. Natl Acad. Sci. USA 110, 20236\u201320241 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"948_CR49","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/imr.12565","volume":"279","author":"JJ Barr","year":"2017","unstructured":"Barr, J. J. A bacteriophages journey through the human body. Immunol. Rev. 279, 106\u2013122 (2017).","journal-title":"Immunol. Rev."},{"key":"948_CR50","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/femsre\/fuaa007","volume":"44","author":"J Kaczorowska","year":"2020","unstructured":"Kaczorowska, J. & van der Hoek, L. Human anelloviruses: diverse, omnipresent and commensal members of the virome. FEMS Microbiol. Rev. 44, 305\u2013313 (2020).","journal-title":"FEMS Microbiol. Rev."},{"key":"948_CR51","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.immuni.2015.05.003","volume":"42","author":"K Cadwell","year":"2015","unstructured":"Cadwell, K. The virome in host health and disease. Immunity 42, 805\u2013813 (2015).","journal-title":"Immunity"},{"key":"948_CR52","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/nature09199","volume":"466","author":"A Reyes","year":"2010","unstructured":"Reyes, A. et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466, 334\u2013338 (2010).","journal-title":"Nature"},{"key":"948_CR53","doi-asserted-by":"publisher","first-page":"e01578","DOI":"10.1128\/mBio.01578-15","volume":"6","author":"GD Hannigan","year":"2015","unstructured":"Hannigan, G. D. et al. The human skin double-stranded DNA virome: topographical and temporal diversity, genetic enrichment, and dynamic associations with the host microbiome. mBio 6, e01578\u201301515 (2015).","journal-title":"mBio"},{"key":"948_CR54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/prd.12393","volume":"87","author":"L Sedghi","year":"2021","unstructured":"Sedghi, L., DiMassa, V., Harrington, A., Lynch, S. V. & Kapila, Y. L. The oral microbiome: role of key organisms and complex networks in oral health and disease. Periodontol. 2000 87, 107\u2013131 (2021).","journal-title":"Periodontol. 2000"},{"key":"948_CR55","doi-asserted-by":"publisher","first-page":"F55","DOI":"10.1016\/j.vaccine.2012.06.083","volume":"30","author":"J Doorbar","year":"2012","unstructured":"Doorbar, J. et al. The biology and life-cycle of human papillomaviruses. Vaccine 30, F55\u2013F70 (2012).","journal-title":"Vaccine"},{"key":"948_CR56","doi-asserted-by":"publisher","first-page":"16272","DOI":"10.1073\/pnas.0806526105","volume":"105","author":"M Shuda","year":"2008","unstructured":"Shuda, M. et al. T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc. Natl Acad. Sci. USA 105, 16272\u201316277 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"948_CR57","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathol-011110-130227","volume":"7","author":"Y Chang","year":"2012","unstructured":"Chang, Y. & Moore, P. S. Merkel cell carcinoma: a virus-induced human cancer. Annu. Rev. Pathol. 7, 123\u2013144 (2012).","journal-title":"Annu. Rev. Pathol."},{"key":"948_CR58","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nature05762","volume":"447","author":"ES Barton","year":"2007","unstructured":"Barton, E. S. et al. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447, 326\u2013329 (2007). A landmark study demonstrating that latent herpesvirus infection confers broad protection against bacterial infection in mice, providing the first evidence of the beneficial effects of persistent viral infection on the host.","journal-title":"Nature"},{"key":"948_CR59","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.micro.55.1.531","volume":"55","author":"S Redpath","year":"2001","unstructured":"Redpath, S., Angulo, A., Gascoigne, N. R. & Ghazal, P. Immune checkpoints in viral latency. Annu. Rev. Microbiol. 55, 531\u2013560 (2001).","journal-title":"Annu. Rev. Microbiol."},{"key":"948_CR60","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1099\/vir.0.020818-0","volume":"91","author":"JN Barr","year":"2010","unstructured":"Barr, J. N. & Fearns, R. How RNA viruses maintain their genome integrity. J. Gen. Virol. 91, 1373\u20131387 (2010).","journal-title":"J. Gen. Virol."},{"key":"948_CR61","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/nri2575","volume":"9","author":"TH Hansen","year":"2009","unstructured":"Hansen, T. H. & Bouvier, M. MHC class I antigen presentation: learning from viral evasion strategies. Nat. Rev. Immunol. 9, 503\u2013513 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"948_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53658-8","volume":"15","author":"C Maguire","year":"2024","unstructured":"Maguire, C. et al. Molecular mimicry as a mechanism of viral immune evasion and autoimmunity. Nat. Commun. 15, 9403 (2024).","journal-title":"Nat. Commun."},{"key":"948_CR63","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.chom.2016.01.010","volume":"19","author":"Z Ma","year":"2016","unstructured":"Ma, Z. & Damania, B. The cGAS-STING defense pathway and its counteraction by viruses. Cell Host Microbe 19, 150\u2013158 (2016).","journal-title":"Cell Host Microbe"},{"key":"948_CR64","doi-asserted-by":"publisher","first-page":"e0065823","DOI":"10.1128\/jvi.00658-23","volume":"97","author":"M Locatelli","year":"2023","unstructured":"Locatelli, M. & Faure-Dupuy, S. Virus hijacking of host epigenetic machinery to impair immune response. J. Virol. 97, e0065823 (2023).","journal-title":"J. Virol."},{"key":"948_CR65","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.4049\/jimmunol.1102516","volume":"188","author":"ZM Huang","year":"2012","unstructured":"Huang, Z. M. et al. Decoy receptor 3 suppresses TLR2-mediated B cell activation by targeting NF-\u03baB. J. Immunol. 188, 5867\u20135876 (2012).","journal-title":"J. Immunol."},{"key":"948_CR66","doi-asserted-by":"publisher","first-page":"e1001191","DOI":"10.1371\/journal.pgen.1001191","volume":"6","author":"A Katzourakis","year":"2010","unstructured":"Katzourakis, A. & Gifford, R. J. Endogenous viral elements in animal genomes. PLoS Genet. 6, e1001191 (2010).","journal-title":"PLoS Genet."},{"key":"948_CR67","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41579-021-00536-5","volume":"19","author":"G Liang","year":"2021","unstructured":"Liang, G. & Bushman, F. D. The human virome: assembly, composition and host interactions. Nat. Rev. Microbiol. 19, 514\u2013527 (2021). A comprehensive review of human virome composition and host interactions, providing an essential reference for the full scope of virome complexity.","journal-title":"Nat. Rev. Microbiol."},{"key":"948_CR68","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/ajpa.10384","volume":"37","author":"LM Van Blerkom","year":"2003","unstructured":"Van Blerkom, L. M. Role of viruses in human evolution. Am. J. Phys. Anthropol. 37, 14\u201346 (2003).","journal-title":"Am. J. Phys. Anthropol."},{"key":"948_CR69","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cell.2009.06.036","volume":"138","author":"HW Virgin","year":"2009","unstructured":"Virgin, H. W., Wherry, E. J. & Ahmed, R. Redefining chronic viral infection. Cell 138, 30\u201350 (2009).","journal-title":"Cell"},{"key":"948_CR70","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/nri3421","volume":"13","author":"L Quintana-Murci","year":"2013","unstructured":"Quintana-Murci, L. & Clark, A. G. Population genetic tools for dissecting innate immunity in humans. Nat. Rev. Immunol. 13, 280\u2013293 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"948_CR71","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nri.2016.27","volume":"16","author":"G Kassiotis","year":"2016","unstructured":"Kassiotis, G. & Stoye, J. P. Immune responses to endogenous retroelements: taking the bad with the good. Nat. Rev. Immunol. 16, 207\u2013219 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"948_CR72","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/35001608","volume":"403","author":"S Mi","year":"2000","unstructured":"Mi, S. et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403, 785\u2013789 (2000). This study showed that a protein essential for human placental morphogenesis is derived from a retroviral envelope gene, providing an early example how ERVs have been co-opted for indispensable host physiological functions.","journal-title":"Nature"},{"key":"948_CR73","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.cell.2017.12.022","volume":"172","author":"J Ashley","year":"2018","unstructured":"Ashley, J. et al. Retrovirus-like gag protein arc1 binds RNA and traffics across synaptic boutons. Cell 172, 262\u2013274 e211 (2018).","journal-title":"Cell"},{"key":"948_CR74","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2018.03.024","volume":"173","author":"ED Pastuzyn","year":"2018","unstructured":"Pastuzyn, E. D. et al. The neuronal gene Arc encodes a repurposed retrotransposon gag protein that mediates intercellular RNA transfer. Cell 173, 275 (2018).","journal-title":"Cell"},{"key":"948_CR75","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1126\/science.abg6155","volume":"373","author":"M Segel","year":"2021","unstructured":"Segel, M. et al. Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery. Science 373, 882\u2013889 (2021).","journal-title":"Science"},{"key":"948_CR76","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrg.2016.139","volume":"18","author":"EB Chuong","year":"2017","unstructured":"Chuong, E. B., Elde, N. C. & Feschotte, C. Regulatory activities of transposable elements: from conflicts to benefits. Nat. Rev. Genet. 18, 71\u201386 (2017).","journal-title":"Nat. Rev. Genet."},{"key":"948_CR77","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.molcel.2016.03.029","volume":"62","author":"PJ Thompson","year":"2016","unstructured":"Thompson, P. J., Macfarlan, T. S. & Lorincz, M. C. Long terminal repeats: from parasitic elements to building blocks of the transcriptional regulatory repertoire. Mol. Cell 62, 766\u2013776 (2016).","journal-title":"Mol. Cell"},{"key":"948_CR78","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.gene.2009.06.020","volume":"448","author":"CJ Cohen","year":"2009","unstructured":"Cohen, C. J., Lock, W. M. & Mager, D. L. Endogenous retroviral LTRs as promoters for human genes: a critical assessment. Gene 448, 105\u2013114 (2009).","journal-title":"Gene"},{"key":"948_CR79","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/ng.600","volume":"42","author":"G Kunarso","year":"2010","unstructured":"Kunarso, G. et al. Transposable elements have rewired the core regulatory network of human embryonic stem cells. Nat. Genet. 42, 631\u2013634 (2010).","journal-title":"Nat. Genet."},{"key":"948_CR80","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.tim.2013.07.001","volume":"21","author":"M Lecuit","year":"2013","unstructured":"Lecuit, M. & Eloit, M. The human virome: new tools and concepts. Trends Microbiol. 21, 510\u2013515 (2013).","journal-title":"Trends Microbiol."},{"key":"948_CR81","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41568-024-00785-5","volume":"25","author":"C Luri-Rey","year":"2025","unstructured":"Luri-Rey, C. et al. Cross-priming in cancer immunology and immunotherapy. Nat. Rev. Cancer 25, 249\u2013273 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"948_CR82","doi-asserted-by":"publisher","first-page":"14725","DOI":"10.1073\/pnas.1110900108","volume":"108","author":"S Lopez-Verges","year":"2011","unstructured":"Lopez-Verges, S. et al. Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl Acad. Sci. USA 108, 14725\u201314732 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"948_CR83","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/eji.201141826","volume":"42","author":"V Beziat","year":"2012","unstructured":"Beziat, V. et al. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 42, 447\u2013457 (2012).","journal-title":"Eur. J. Immunol."},{"key":"948_CR84","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","volume":"42","author":"H Schlums","year":"2015","unstructured":"Schlums, H. et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 42, 443\u2013456 (2015).","journal-title":"Immunity"},{"key":"948_CR85","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1084\/jem.20050882","volume":"202","author":"AW Sylwester","year":"2005","unstructured":"Sylwester, A. W. et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202, 673\u2013685 (2005).","journal-title":"J. Exp. Med."},{"key":"948_CR86","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1182\/blood-2003-08-2674","volume":"103","author":"A Krug","year":"2004","unstructured":"Krug, A. et al. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 103, 1433\u20131437 (2004).","journal-title":"Blood"},{"key":"948_CR87","doi-asserted-by":"publisher","first-page":"11416","DOI":"10.1073\/pnas.0403555101","volume":"101","author":"H Hochrein","year":"2004","unstructured":"Hochrein, H. et al. Herpes simplex virus type-1 induces IFN-\u03b1 production via Toll-like receptor 9-dependent and -independent pathways. Proc. Natl Acad. Sci. USA 101, 11416\u201311421 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"948_CR88","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1084\/jem.20150712","volume":"213","author":"S Madera","year":"2016","unstructured":"Madera, S. et al. Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide. J. Exp. Med. 213, 225\u2013233 (2016).","journal-title":"J. Exp. Med."},{"key":"948_CR89","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1084\/jem.20160880","volume":"214","author":"AJ Lee","year":"2017","unstructured":"Lee, A. J. et al. Inflammatory monocytes require type I interferon receptor signaling to activate NK cells via IL-18 during a mucosal viral infection. J. Exp. Med. 214, 1153\u20131167 (2017).","journal-title":"J. Exp. Med."},{"key":"948_CR90","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/bjc.2017.360","volume":"118","author":"J Hwee","year":"2018","unstructured":"Hwee, J. et al. A systematic review and meta-analysis of the association between childhood infections and the risk of childhood acute lymphoblastic leukaemia. Br. J. Cancer 118, 127\u2013137 (2018).","journal-title":"Br. J. Cancer"},{"key":"948_CR91","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/ijc.27438","volume":"131","author":"N Becker","year":"2012","unstructured":"Becker, N. et al. Self-reported history of infections and the risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Int. J. Cancer 131, 2342\u20132348 (2012).","journal-title":"Int. J. Cancer"},{"key":"948_CR92","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1093\/oxfordjournals.aje.a009155","volume":"145","author":"M Wrensch","year":"1997","unstructured":"Wrensch, M. et al. Does prior infection with varicella-zoster virus influence risk of adult glioma? Am. J. Epidemiol. 145, 594\u2013597 (1997).","journal-title":"Am. J. Epidemiol."},{"key":"948_CR93","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1165\/rcmb.2004-0417OC","volume":"34","author":"Y Chen","year":"2006","unstructured":"Chen, Y. et al. Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways. Am. J. Respir. Cell Mol. Biol. 34, 192\u2013203 (2006).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"948_CR94","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature13960","volume":"516","author":"E Kernbauer","year":"2014","unstructured":"Kernbauer, E., Ding, Y. & Cadwell, K. An enteric virus can replace the beneficial function of commensal bacteria. Nature 516, 94\u201398 (2014).","journal-title":"Nature"},{"key":"948_CR95","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1084\/jem.188.9.1705","volume":"188","author":"LK Selin","year":"1998","unstructured":"Selin, L. K., Varga, S. M., Wong, I. C. & Welsh, R. M. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. Med. 188, 1705\u20131715 (1998).","journal-title":"J. Exp. Med."},{"key":"948_CR96","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41586-025-09655-y","volume":"647","author":"AJ Grippin","year":"2025","unstructured":"Grippin, A. J. et al. SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockade. Nature 647, 488\u2013497 (2025). This study demonstrated that SARS-CoV-2 mRNA vaccination sensitizes tumors to ICB, connecting vaccine-induced antiviral immunity to the enhancement of cancer immunotherapy.","journal-title":"Nature"},{"key":"948_CR97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13035-2","volume":"10","author":"Y Kong","year":"2019","unstructured":"Kong, Y. et al. Transposable element expression in tumors is associated with immune infiltration and increased antigenicity. Nat. Commun. 10, 5228 (2019).","journal-title":"Nat. Commun."},{"key":"948_CR98","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nrmicro2222","volume":"7","author":"NC Elde","year":"2009","unstructured":"Elde, N. C. & Malik, H. S. The evolutionary conundrum of pathogen mimicry. Nat. Rev. Microbiol. 7, 787\u2013797 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"948_CR99","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.immuni.2013.06.014","volume":"39","author":"L Zitvogel","year":"2013","unstructured":"Zitvogel, L., Galluzzi, L., Smyth, M. J. & Kroemer, G. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity 39, 74\u201388 (2013).","journal-title":"Immunity"},{"key":"948_CR100","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","volume":"603","author":"TV Lanz","year":"2022","unstructured":"Lanz, T. V. et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603, 321\u2013327 (2022).","journal-title":"Nature"},{"key":"948_CR101","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1158\/2326-6066.CIR-20-0814","volume":"9","author":"J Chiaro","year":"2021","unstructured":"Chiaro, J. et al. Viral molecular mimicry influences the antitumor immune response in murine and human melanoma. Cancer Immunol. Res. 9, 981\u2013993 (2021). This study provides direct experimental evidence that viral molecular mimicry shapes the antitumour immune response in both mouse and human melanoma.","journal-title":"Cancer Immunol. Res."},{"key":"948_CR102","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.immuni.2021.02.014","volume":"54","author":"SH Chiou","year":"2021","unstructured":"Chiou, S. H. et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity 54, 586\u2013602 e588 (2021).","journal-title":"Immunity"},{"key":"948_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03681-4","volume":"20","author":"C Manolio","year":"2022","unstructured":"Manolio, C. et al. Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case. J. Transl. Med. 20, 472 (2022).","journal-title":"J. Transl. Med."},{"key":"948_CR104","doi-asserted-by":"publisher","first-page":"1398002","DOI":"10.3389\/fimmu.2024.1398002","volume":"15","author":"C Ragone","year":"2024","unstructured":"Ragone, C. et al. Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization. Front. Immunol. 15, 1398002 (2024).","journal-title":"Front. Immunol."},{"key":"948_CR105","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/ni1129","volume":"5","author":"CM Smith","year":"2004","unstructured":"Smith, C. M. et al. Cognate CD4+ T cell licensing of dendritic cells in CD8+ T cell immunity. Nat. Immunol. 5, 1143\u20131148 (2004).","journal-title":"Nat. Immunol."},{"key":"948_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13438-1","volume":"10","author":"T Ahrends","year":"2019","unstructured":"Ahrends, T. et al. CD4+ T cell help creates memory CD8+ T cells with innate and help-independent recall capacities. Nat. Commun. 10, 5531 (2019).","journal-title":"Nat. Commun."},{"key":"948_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45612-5","volume":"15","author":"K English","year":"2024","unstructured":"English, K. et al. A hepatic network of dendritic cells mediates CD4 T cell help outside lymphoid organs. Nat. Commun. 15, 1261 (2024).","journal-title":"Nat. Commun."},{"key":"948_CR108","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","volume":"18","author":"J Borst","year":"2018","unstructured":"Borst, J., Ahrends, T., Babala, N., Melief, C. J. M. & Kastenmuller, W. CD4+ T cell help in cancer immunology and immunotherapy. Nat. Rev. Immunol. 18, 635\u2013647 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"948_CR109","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s00262-025-03975-8","volume":"74","author":"MJ Campa","year":"2025","unstructured":"Campa, M. J., Gottlin, E. B., Wiehe, K. & Patz, E. F. Jr. A tumor-binding antibody with cross-reactivity to viral antigens. Cancer Immunol. Immunother. 74, 126 (2025).","journal-title":"Cancer Immunol. Immunother."},{"key":"948_CR110","doi-asserted-by":"publisher","unstructured":"Hung, M. H. et al. Enteroviral epitope mimicry enables NK cell-mediated targeting of ASPH in hepatocellular carcinoma. Preprint at bioRxiv https:\/\/doi.org\/10.64898\/2026.04.07.717032 (2026). A preprint showing that enteroviral epitope mimicry enables natural killer cell-mediated targeting of the tumour antigen ASPH in HCC.","DOI":"10.64898\/2026.04.07.717032"},{"key":"948_CR111","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1136\/gutjnl-2024-334681","volume":"74","author":"L Ma","year":"2025","unstructured":"Ma, L. et al. Beneficial infections of the enterovirus genus in patients with liver cancer. Gut 74, 1667\u20131679 (2025). The key primary paper underlying this Review\u2019s central thesis, demonstrating that enterovirus exposure is associated with protective antitumour immunity in patients with liver cancer and identifying a specific mechanism based on a cross-reactive epitope.","journal-title":"Gut"},{"key":"948_CR112","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/s41586-021-03368-8","volume":"592","author":"S Kalaora","year":"2021","unstructured":"Kalaora, S. et al. Identification of bacteria-derived HLA-bound peptides in melanoma. Nature 592, 138\u2013143 (2021).","journal-title":"Nature"},{"key":"948_CR113","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41586-023-06081-w","volume":"617","author":"R Naghavian","year":"2023","unstructured":"Naghavian, R. et al. Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma. Nature 617, 807\u2013817 (2023).","journal-title":"Nature"},{"key":"948_CR114","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/375685a0","volume":"375","author":"J Levitskaya","year":"1995","unstructured":"Levitskaya, J. et al. Inhibition of antigen processing by the internal repeat region of the Epstein\u2013Barr virus nuclear antigen-1. Nature 375, 685\u2013688 (1995).","journal-title":"Nature"},{"key":"948_CR115","doi-asserted-by":"publisher","first-page":"12189","DOI":"10.18632\/oncotarget.2608","volume":"5","author":"W Fang","year":"2014","unstructured":"Fang, W. et al. EBV-driven LMP1 and IFN-gamma up-regulate PD-L1 in nasopharyngeal carcinoma: implications for oncotargeted therapy. Oncotarget 5, 12189\u201312202 (2014).","journal-title":"Oncotarget"},{"key":"948_CR116","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3892\/mmr.2017.6102","volume":"15","author":"C Liu","year":"2017","unstructured":"Liu, C. et al. Increased expression of PD-L1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity. Mol. Med. Rep. 15, 1063\u20131070 (2017).","journal-title":"Mol. Med. Rep."},{"key":"948_CR117","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.virol.2019.07.024","volume":"536","author":"J Chen","year":"2019","unstructured":"Chen, J. et al. Expression of PD-1 and PD-Ls in Kaposi\u2019s sarcoma and regulation by oncogenic herpesvirus lytic reactivation. Virology 536, 16\u201319 (2019).","journal-title":"Virology"},{"key":"948_CR118","doi-asserted-by":"publisher","first-page":"e00917","DOI":"10.1128\/mBio.00917-17","volume":"8","author":"KM Host","year":"2017","unstructured":"Host, K. M. et al. Kaposi\u2019s sarcoma-associated herpesvirus increases PD-L1 and proinflammatory cytokine expression in human monocytes. mBio 8, e00917\u2013e00917 (2017).","journal-title":"mBio"},{"key":"948_CR119","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1128\/JVI.74.11.5300-5309.2000","volume":"74","author":"S Ishido","year":"2000","unstructured":"Ishido, S., Wang, C., Lee, B. S., Cohen, G. B. & Jung, J. U. Downregulation of major histocompatibility complex class I molecules by Kaposi\u2019s sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 74, 5300\u20135309 (2000).","journal-title":"J. Virol."},{"key":"948_CR120","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.1073\/pnas.96.15.8516","volume":"96","author":"CM Story","year":"1999","unstructured":"Story, C. M., Furman, M. H. & Ploegh, H. L. The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products. Proc. Natl Acad. Sci. USA 96, 8516\u20138521 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"948_CR121","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0092-8674(00)81054-5","volume":"84","author":"EJ Wiertz","year":"1996","unstructured":"Wiertz, E. J. et al. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84, 769\u2013779 (1996).","journal-title":"Cell"},{"key":"948_CR122","doi-asserted-by":"publisher","first-page":"e0119124","DOI":"10.1128\/mbio.01191-24","volume":"15","author":"Q Yuan","year":"2024","unstructured":"Yuan, Q. et al. Human cytomegalovirus UL23 exploits PD-L1 inhibitory signaling pathway to evade T cell-mediated cytotoxicity. mBio 15, e0119124 (2024).","journal-title":"mBio"},{"key":"948_CR123","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/QAD.0b013e3282f4de23","volume":"22","author":"A Meier","year":"2008","unstructured":"Meier, A. et al. Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands. AIDS 22, 655\u2013658 (2008).","journal-title":"AIDS"},{"key":"948_CR124","doi-asserted-by":"publisher","first-page":"6672","DOI":"10.1128\/JVI.00825-14","volume":"88","author":"R Planes","year":"2014","unstructured":"Planes, R. et al. HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through tumor necrosis factor alpha- and toll-like receptor 4-mediated mechanisms. J. Virol. 88, 6672\u20136689 (2014).","journal-title":"J. Virol."},{"key":"948_CR125","doi-asserted-by":"publisher","first-page":"11536","DOI":"10.1128\/JVI.00485-08","volume":"82","author":"K Muthumani","year":"2008","unstructured":"Muthumani, K. et al. Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism. J. Virol. 82, 11536\u201311544 (2008).","journal-title":"J. Virol."},{"key":"948_CR126","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1084\/jem.185.9.1565","volume":"185","author":"B Galocha","year":"1997","unstructured":"Galocha, B. et al. The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. J. Exp. Med. 185, 1565\u20131572 (1997).","journal-title":"J. Exp. Med."},{"key":"948_CR127","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682\u2013687 (2006).","journal-title":"Nature"},{"key":"948_CR128","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1128\/JVI.02021-06","volume":"81","author":"H Radziewicz","year":"2007","unstructured":"Radziewicz, H. et al. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J. Virol. 81, 2545\u20132553 (2007).","journal-title":"J. Virol."},{"key":"948_CR129","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.jhep.2007.12.014","volume":"48","author":"S Urbani","year":"2008","unstructured":"Urbani, S. et al. Restoration of HCV-specific T cell functions by PD-1\/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. J. Hepatol. 48, 548\u2013558 (2008).","journal-title":"J. Hepatol."},{"key":"948_CR130","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","volume":"138","author":"P Fisicaro","year":"2010","unstructured":"Fisicaro, P. et al. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 138, 682\u2013693 (2010).","journal-title":"Gastroenterology"},{"key":"948_CR131","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/cgt.2015.40","volume":"22","author":"AE Rice","year":"2015","unstructured":"Rice, A. E. et al. An HPV-E6\/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression. Cancer Gene Ther. 22, 454\u2013462 (2015).","journal-title":"Cancer Gene Ther."},{"key":"948_CR132","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1172\/JCI67008","volume":"123","author":"EE West","year":"2013","unstructured":"West, E. E. et al. PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells. J. Clin. Invest. 123, 2604\u20132615 (2013).","journal-title":"J. Clin. Invest."},{"key":"948_CR133","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1134\/S0026893312050032","volume":"46","author":"PM Chumakov","year":"2012","unstructured":"Chumakov, P. M. et al. Oncolytic enteroviruses. Mol. Biol. 46, 712\u2013725 (2012).","journal-title":"Mol. Biol."},{"key":"948_CR134","first-page":"191","volume":"36","author":"MK Voroshilova","year":"1989","unstructured":"Voroshilova, M. K. Potential use of nonpathogenic enteroviruses for control of human disease. Prog. Med. Virol. 36, 191\u2013202 (1989). An early study of the potential for non-pathogenic enteroviruses to control human disease, enlightening oncolytic virotherapy using naturally occurring enteroviruses.","journal-title":"Prog. Med. Virol."},{"key":"948_CR135","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2020.05.038","volume":"182","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. A viral exposure signature defines early onset of hepatocellular carcinoma. Cell 182, 317\u2013328 e310 (2020). This study used comprehensive viral exposure profiling to identify a virome signature that predicts early-onset HCC, demonstrating that systematic virome serology can serve as a cancer risk biomarker.","journal-title":"Cell"},{"key":"948_CR136","first-page":"12","volume":"4","author":"WL Do","year":"2023","unstructured":"Do, W. L. et al. Pan-viral serology uncovers distinct virome patterns as risk predictors of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cell Rep. Med. 4, 12 (2023).","journal-title":"Cell Rep. Med."},{"key":"948_CR137","doi-asserted-by":"publisher","first-page":"aaa0698","DOI":"10.1126\/science.aaa0698","volume":"348","author":"GJ Xu","year":"2015","unstructured":"Xu, G. J. et al. Viral immunology. comprehensive serological profiling of human populations using a synthetic human virome. Science 348, aaa0698 (2015).","journal-title":"Science"},{"key":"948_CR138","doi-asserted-by":"crossref","unstructured":"Palmenberg, A. C. & Gern, J. E. in Rhinoviruses 1\u201310 (Springer, 2015).","DOI":"10.1007\/978-1-4939-1571-2_1"},{"key":"948_CR139","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(03)12162-9","volume":"361","author":"T Heikkinen","year":"2003","unstructured":"Heikkinen, T. & Jarvinen, A. The common cold. Lancet 361, 51\u201359 (2003).","journal-title":"Lancet"},{"key":"948_CR140","doi-asserted-by":"publisher","first-page":"e21116","DOI":"10.1371\/journal.pone.0021116","volume":"6","author":"CB Tran","year":"2011","unstructured":"Tran, C. B. et al. The seroprevalence and seroincidence of enterovirus71 infection in infants and children in Ho Chi Minh City, Viet Nam. PLoS ONE 6, e21116 (2011).","journal-title":"PLoS ONE"},{"key":"948_CR141","doi-asserted-by":"publisher","first-page":"e0010073","DOI":"10.1371\/journal.pntd.0010073","volume":"16","author":"A Fall","year":"2022","unstructured":"Fall, A. et al. Global prevalence and case fatality rate of enterovirus D68 infections, a systematic review and meta-analysis. PLoS Negl. Trop. Dis. 16, e0010073 (2022).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"948_CR142","doi-asserted-by":"publisher","first-page":"13790","DOI":"10.1073\/pnas.191502998","volume":"98","author":"A Bhattacharjee","year":"2001","unstructured":"Bhattacharjee, A. et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl Acad. Sci. USA 98, 13790\u201313795 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"948_CR143","doi-asserted-by":"publisher","first-page":"e1008814","DOI":"10.1371\/journal.ppat.1008814","volume":"16","author":"D Pyeon","year":"2020","unstructured":"Pyeon, D., Vu, L., Giacobbi, N. S. & Westrich, J. A. The antiviral immune forces awaken in the cancer wars. PLoS Pathog. 16, e1008814 (2020).","journal-title":"PLoS Pathog."},{"key":"948_CR144","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","volume":"162","author":"KB Chiappinelli","year":"2015","unstructured":"Chiappinelli, K. B. et al. Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses. Cell 162, 974\u2013986 (2015). This study showed that DNA demethylation in cancer cells de-represses ERVs and triggers an interferon response that resensitizes tumours to immunity.","journal-title":"Cell"},{"key":"948_CR145","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","volume":"162","author":"D Roulois","year":"2015","unstructured":"Roulois, D. et al. DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts. Cell 162, 961\u2013973 (2015).","journal-title":"Cell"},{"key":"948_CR146","doi-asserted-by":"publisher","first-page":"e001519","DOI":"10.1136\/jitc-2020-001519","volume":"9","author":"M Natoli","year":"2021","unstructured":"Natoli, M. et al. Transcriptional analysis of multiple ovarian cancer cohorts reveals prognostic and immunomodulatory consequences of ERV expression. J. Immunother. Cancer 9, e001519 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"948_CR147","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41525-021-00177-w","volume":"6","author":"M Golkaram","year":"2021","unstructured":"Golkaram, M. et al. HERVs establish a distinct molecular subtype in stage II\/III colorectal cancer with poor outcome. npj Genom. Med. 6, 13 (2021).","journal-title":"npj Genom. Med."},{"key":"948_CR148","first-page":"5510","volume":"62","author":"F Schiavetti","year":"2002","unstructured":"Schiavetti, F., Thonnard, J., Colau, D., Boon, T. & Coulie, P. G. A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes. Cancer Res. 62, 5510\u20135516 (2002).","journal-title":"Cancer Res."},{"key":"948_CR149","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1158\/0008-5472.CAN-15-3139","volume":"76","author":"E Cherkasova","year":"2016","unstructured":"Cherkasova, E. et al. Detection of an immunogenic HERV-E envelope with selective expression in clear cell kidney cancer. Cancer Res. 76, 2177\u20132185 (2016).","journal-title":"Cancer Res."},{"key":"948_CR150","doi-asserted-by":"publisher","first-page":"5869","DOI":"10.1158\/0008-5472.CAN-07-6838","volume":"68","author":"F Wang-Johanning","year":"2008","unstructured":"Wang-Johanning, F. et al. Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res. 68, 5869\u20135877 (2008).","journal-title":"Cancer Res."},{"key":"948_CR151","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ijc.22256","volume":"120","author":"F Wang-Johanning","year":"2007","unstructured":"Wang-Johanning, F. et al. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int. J. Cancer 120, 81\u201390 (2007).","journal-title":"Int. J. Cancer"},{"key":"948_CR152","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/s41591-018-0116-5","volume":"24","author":"I Ca\u00f1adas","year":"2018","unstructured":"Ca\u00f1adas, I. et al. Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses. Nat. Med. 24, 1143\u20131150 (2018). This study demonstrated that specific interferon-stimulated ERVs can prime innate immunity against tumours, providing evidence that ERV expression drives antitumour immune responses.","journal-title":"Nat. Med."},{"key":"948_CR153","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nbt.2287","volume":"30","author":"SJ Russell","year":"2012","unstructured":"Russell, S. J., Peng, K. W. & Bell, J. C. Oncolytic virotherapy. Nat. Biotechnol. 30, 658\u2013670 (2012).","journal-title":"Nat. Biotechnol."},{"key":"948_CR154","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41573-019-0029-0","volume":"18","author":"K Harrington","year":"2019","unstructured":"Harrington, K., Freeman, D. J., Kelly, B., Harper, J. & Soria, J. C. Optimizing oncolytic virotherapy in cancer treatment. Nat. Rev. Drug Discov. 18, 689\u2013706 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"948_CR155","doi-asserted-by":"publisher","first-page":"11099","DOI":"10.1073\/pnas.0404310101","volume":"101","author":"KL Norman","year":"2004","unstructured":"Norman, K. L., Hirasawa, K., Yang, A. D., Shields, M. A. & Lee, P. W. Reovirus oncolysis: the Ras\/RalGEF\/p38 pathway dictates host cell permissiveness to reovirus infection. Proc. Natl Acad. Sci. USA 101, 11099\u201311104 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"948_CR156","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1126\/science.282.5392.1332","volume":"282","author":"MC Coffey","year":"1998","unstructured":"Coffey, M. C., Strong, J. E., Forsyth, P. A. & Lee, P. W. Reovirus therapy of tumors with activated Ras pathway. Science 282, 1332\u20131334 (1998).","journal-title":"Science"},{"key":"948_CR157","doi-asserted-by":"publisher","first-page":"7127","DOI":"10.1158\/1078-0432.CCR-08-0524","volume":"14","author":"L Vidal","year":"2008","unstructured":"Vidal, L. et al. A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer. Clin. Cancer Res. 14, 7127\u20137137 (2008).","journal-title":"Clin. Cancer Res."},{"key":"948_CR158","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/sj.mt.6300403","volume":"16","author":"P Forsyth","year":"2008","unstructured":"Forsyth, P. et al. A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas. Mol. Ther. 16, 627\u2013632 (2008).","journal-title":"Mol. Ther."},{"key":"948_CR159","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1158\/1078-0432.CCR-10-0054","volume":"16","author":"KJ Harrington","year":"2010","unstructured":"Harrington, K. J. et al. Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers. Clin. Cancer Res. 16, 3067\u20133077 (2010).","journal-title":"Clin. Cancer Res."},{"key":"948_CR160","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1158\/1078-0432.CCR-19-2078","volume":"26","author":"D Mahalingam","year":"2020","unstructured":"Mahalingam, D. et al. Pembrolizumab in combination with the oncolytic virus pelareorep and chemotherapy in patients with advanced pancreatic adenocarcinoma: a phase Ib study. Clin. Cancer Res. 26, 71\u201381 (2020).","journal-title":"Clin. Cancer Res."},{"key":"948_CR161","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1200\/JCO.20.03246","volume":"39","author":"RHI Andtbacka","year":"2021","unstructured":"Andtbacka, R. H. I. et al. Clinical responses of oncolytic coxsackievirus A21 (V937) in patients with unresectable melanoma. J. Clin. Oncol. 39, 3829\u20133838 (2021).","journal-title":"J. Clin. Oncol."},{"key":"948_CR162","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1200\/JCO.2002.08.042","volume":"20","author":"AL Pecora","year":"2002","unstructured":"Pecora, A. L. et al. Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers. J. Clin. Oncol. 20, 2251\u20132266 (2002).","journal-title":"J. Clin. Oncol."},{"key":"948_CR163","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1016\/j.ymthe.2017.08.016","volume":"25","author":"K Geletneky","year":"2017","unstructured":"Geletneky, K. et al. Oncolytic H-1 parvovirus shows safety and signs of immunogenic activity in a first phase I\/IIa glioblastoma trial. Mol. Ther. 25, 2620\u20132634 (2017).","journal-title":"Mol. Ther."},{"key":"948_CR164","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1200\/JCO.2014.58.3377","volume":"33","author":"RH Andtbacka","year":"2015","unstructured":"Andtbacka, R. H. et al. Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. J. Clin. Oncol. 33, 2780\u20132788 (2015). The landmark phase III trial of talimogene laherparepvec (T-VEC), which led to the first FDA-approved oncolytic virus therapy for advanced melanoma and validating this therapeutic approach.","journal-title":"J. Clin. Oncol."},{"key":"948_CR165","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nm.3089","volume":"19","author":"J Heo","year":"2013","unstructured":"Heo, J. et al. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. Nat. Med. 19, 329\u2013336 (2013).","journal-title":"Nat. Med."},{"key":"948_CR166","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1056\/NEJMoa1716435","volume":"379","author":"A Desjardins","year":"2018","unstructured":"Desjardins, A. et al. Recurrent glioblastoma treated with recombinant poliovirus. N. Engl. J. Med. 379, 150\u2013161 (2018).","journal-title":"N. Engl. J. Med."},{"key":"948_CR167","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.mayocp.2014.04.003","volume":"89","author":"SJ Russell","year":"2014","unstructured":"Russell, S. J. et al. Remission of disseminated cancer after systemic oncolytic virotherapy. Mayo Clin. Proc. 89, 926\u2013933 (2014).","journal-title":"Mayo Clin. Proc."},{"key":"948_CR168","doi-asserted-by":"publisher","first-page":"1279387","DOI":"10.3389\/fimmu.2023.1279387","volume":"14","author":"KER Smith","year":"2023","unstructured":"Smith, K. E. R. et al. A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses. Front. Immunol. 14, 1279387 (2023).","journal-title":"Front. Immunol."},{"key":"948_CR169","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/78638","volume":"6","author":"FR Khuri","year":"2000","unstructured":"Khuri, F. R. et al. a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat. Med. 6, 879\u2013885 (2000).","journal-title":"Nat. Med."},{"key":"948_CR170","doi-asserted-by":"publisher","first-page":"eabc4552","DOI":"10.1126\/science.abc4552","volume":"371","author":"GD Sepich-Poore","year":"2021","unstructured":"Sepich-Poore, G. D. et al. The microbiome and human cancer. Science 371, eabc4552 (2021).","journal-title":"Science"},{"key":"948_CR171","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.immuni.2017.04.008","volume":"46","author":"Y Belkaid","year":"2017","unstructured":"Belkaid, Y. & Harrison, O. J. Homeostatic immunity and the microbiota. Immunity 46, 562\u2013576 (2017).","journal-title":"Immunity"},{"key":"948_CR172","doi-asserted-by":"publisher","first-page":"10771","DOI":"10.1073\/pnas.1305923110","volume":"110","author":"JJ Barr","year":"2013","unstructured":"Barr, J. J. et al. Bacteriophage adhering to mucus provide a non-host-derived immunity. Proc. Natl Acad. Sci. USA 110, 10771\u201310776 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"948_CR173","doi-asserted-by":"publisher","first-page":"e01874","DOI":"10.1128\/mBio.01874-17","volume":"8","author":"S Nguyen","year":"2017","unstructured":"Nguyen, S. et al. Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers. mBio 8, e01874\u201317 (2017).","journal-title":"mBio"},{"key":"948_CR174","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.chom.2019.01.008","volume":"25","author":"L Gogokhia","year":"2019","unstructured":"Gogokhia, L. et al. Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis. Cell Host Microbe 25, 285\u2013299 e288 (2019).","journal-title":"Cell Host Microbe"},{"key":"948_CR175","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1016\/j.cell.2022.07.003","volume":"185","author":"S Federici","year":"2022","unstructured":"Federici, S. et al. Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation. Cell 185, 2879\u20132898 e2824 (2022).","journal-title":"Cell"},{"key":"948_CR176","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39029-9","volume":"14","author":"M Ichikawa","year":"2023","unstructured":"Ichikawa, M. et al. Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis. Nat. Commun. 14, 3261 (2023).","journal-title":"Nat. Commun."},{"key":"948_CR177","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1084\/jem.20031636","volume":"199","author":"CJ de Haas","year":"2004","unstructured":"de Haas, C. J. et al. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J. Exp. Med. 199, 687\u2013695 (2004).","journal-title":"J. Exp. Med."},{"key":"948_CR178","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","volume":"139","author":"II Ivanov","year":"2009","unstructured":"Ivanov, I. I. et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485\u2013498 (2009).","journal-title":"Cell"},{"key":"948_CR179","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446\u2013450 (2013).","journal-title":"Nature"},{"key":"948_CR180","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia, N. et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451\u2013455 (2013).","journal-title":"Nature"},{"key":"948_CR181","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","volume":"39","author":"T Zelante","year":"2013","unstructured":"Zelante, T. et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39, 372\u2013385 (2013).","journal-title":"Immunity"},{"key":"948_CR182","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01486-1","volume":"11","author":"JS Mar","year":"2023","unstructured":"Mar, J. S. et al. IL-22 alters gut microbiota composition and function to increase aryl hydrocarbon receptor activity in mice and humans. Microbiome 11, 47 (2023).","journal-title":"Microbiome"},{"key":"948_CR183","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1126\/science.aam5336","volume":"357","author":"AL Steed","year":"2017","unstructured":"Steed, A. L. et al. The microbial metabolite desaminotyrosine protects from influenza through type I interferon. Science 357, 498\u2013502 (2017).","journal-title":"Science"},{"key":"948_CR184","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","volume":"350","author":"A Sivan","year":"2015","unstructured":"Sivan, A. et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350, 1084\u20131089 (2015).","journal-title":"Science"},{"key":"948_CR185","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou, M. et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079\u20131084 (2015). Along with Sivan et al. (2015), this study demonstrates that the gut microbiome is required for the efficacy of ICB therapy, establishing the microbiome as a major determinant of therapy outcome.","journal-title":"Science"},{"key":"948_CR186","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41423-020-00532-4","volume":"18","author":"S Federici","year":"2021","unstructured":"Federici, S., Nobs, S. P. & Elinav, E. Phages and their potential to modulate the microbiome and immunity. Cell Mol. Immunol. 18, 889\u2013904 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"948_CR187","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-020-00785-5","volume":"18","author":"R Kumata","year":"2020","unstructured":"Kumata, R., Ito, J., Takahashi, K., Suzuki, T. & Sato, K. A tissue level atlas of the healthy human virome. BMC Biol. 18, 55 (2020).","journal-title":"BMC Biol."},{"key":"948_CR188","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/cei.12785","volume":"185","author":"AB Bigley","year":"2016","unstructured":"Bigley, A. B. et al. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans. Clin. Exp. immunol. 185, 239\u2013251 (2016). This study provides direct evidence that a common persistent virus can enhance immune surveillance against cancer in humans.","journal-title":"Clin. Exp. immunol."},{"key":"948_CR189","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.leukres.2005.11.020","volume":"30","author":"M Montella","year":"2006","unstructured":"Montella, M. et al. Do childhood diseases affect NHL and HL risk? A case\u2013control study from northern and southern Italy. Leuk. Res. 30, 917\u2013922 (2006).","journal-title":"Leuk. Res."},{"key":"948_CR190","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41586-019-1719-9","volume":"575","author":"JD Strickley","year":"2019","unstructured":"Strickley, J. D. et al. Immunity to commensal papillomaviruses protects against skin cancer. Nature 575, 519\u2013522 (2019).","journal-title":"Nature"},{"key":"948_CR191","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ccell.2024.11.013","volume":"43","author":"HG Son","year":"2025","unstructured":"Son, H. G. et al. Commensal papillomavirus immunity preserves the homeostasis of highly mutated normal skin. Cancer Cell 43, 36\u201348 e10 (2025).","journal-title":"Cancer Cell"},{"key":"948_CR192","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1084\/jem.191.4.625","volume":"191","author":"E Jager","year":"2000","unstructured":"Jager, E. et al. Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4+ T lymphocytes of patients with NY-ESO-1-expressing melanoma. J. Exp. Med. 191, 625\u2013630 (2000).","journal-title":"J. Exp. Med."},{"key":"948_CR193","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","volume":"29","author":"PF Robbins","year":"2011","unstructured":"Robbins, P. F. et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J. Clin. Oncol. 29, 917\u2013924 (2011).","journal-title":"J. Clin. Oncol."},{"key":"948_CR194","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1158\/1078-0432.CCR-14-2708","volume":"21","author":"PF Robbins","year":"2015","unstructured":"Robbins, P. F. et al. A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response. Clin. Cancer Res. 21, 1019\u20131027 (2015).","journal-title":"Clin. Cancer Res."},{"key":"948_CR195","doi-asserted-by":"publisher","first-page":"12837","DOI":"10.1073\/pnas.0703342104","volume":"104","author":"K Odunsi","year":"2007","unstructured":"Odunsi, K. et al. Vaccination with an NY-ESO-1 peptide of HLA class I\/II specificities induces integrated humoral and T cell responses in ovarian cancer. Proc. Natl Acad. Sci. USA 104, 12837\u201312842 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"948_CR196","doi-asserted-by":"publisher","first-page":"12198","DOI":"10.1073\/pnas.220413497","volume":"97","author":"E Jager","year":"2000","unstructured":"Jager, E. et al. Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc. Natl Acad. Sci. USA 97, 12198\u201312203 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"948_CR197","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","volume":"116","author":"T Feuchtinger","year":"2010","unstructured":"Feuchtinger, T. et al. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. Blood 116, 4360\u20134367 (2010).","journal-title":"Blood"},{"key":"948_CR198","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.humimm.2004.02.005","volume":"65","author":"SJ Paston","year":"2004","unstructured":"Paston, S. J., Dodi, I. A. & Madrigal, J. A. Progress made towards the development of a CMV peptide vaccine. Hum. Immunol. 65, 544\u2013549 (2004).","journal-title":"Hum. Immunol."},{"key":"948_CR199","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/s43018-025-00998-z","volume":"6","author":"EM Thompson","year":"2025","unstructured":"Thompson, E. M. et al. A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial. Nat. Cancer 6, 1559\u20131569 (2025).","journal-title":"Nat. Cancer"},{"key":"948_CR200","doi-asserted-by":"publisher","first-page":"e165476","DOI":"10.1172\/JCI165476","volume":"133","author":"SE Prockop","year":"2023","unstructured":"Prockop, S. E. et al. Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant. J. Clin. Invest. 133, e165476 (2023).","journal-title":"J. Clin. Invest."},{"key":"948_CR201","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1038\/s41596-018-0025-6","volume":"13","author":"D Mohan","year":"2018","unstructured":"Mohan, D. et al. PhIP-seq characterization of serum antibodies using oligonucleotide-encoded peptidomes. Nat. Protoc. 13, 1958\u20131978 (2018).","journal-title":"Nat. Protoc."},{"key":"948_CR202","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/j.immuni.2023.04.017","volume":"56","author":"AR Bourgonje","year":"2023","unstructured":"Bourgonje, A. R. et al. Phage-display immunoprecipitation sequencing of the antibody epitope repertoire in inflammatory bowel disease reveals distinct antibody signatures. Immunity 56, 1393\u20131409 e1396 (2023).","journal-title":"Immunity"},{"key":"948_CR203","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.immuni.2023.04.003","volume":"56","author":"S Andreu-Sanchez","year":"2023","unstructured":"Andreu-Sanchez, S. et al. Phage display sequencing reveals that genetic, environmental, and intrinsic factors influence variation of human antibody epitope repertoire. Immunity 56, 1376\u20131392 e1378 (2023).","journal-title":"Immunity"},{"key":"948_CR204","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1126\/science.aay6485","volume":"366","author":"MJ Mina","year":"2019","unstructured":"Mina, M. J. et al. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science 366, 599\u2013606 (2019).","journal-title":"Science"},{"key":"948_CR205","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29307-3","volume":"13","author":"AJ Mentzer","year":"2022","unstructured":"Mentzer, A. J. et al. Identification of host-pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank. Nat. Commun. 13, 1818 (2022).","journal-title":"Nat. Commun."},{"key":"948_CR206","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1200\/JCO.21.01785","volume":"40","author":"HA Robbins","year":"2022","unstructured":"Robbins, H. A. et al. Absolute risk of oropharyngeal cancer after an HPV16-E6 serology test and potential implications for screening: results from the human papillomavirus cancer cohort consortium. J. Clin. Oncol. 40, 3613\u20133622 (2022).","journal-title":"J. Clin. Oncol."},{"key":"948_CR207","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1158\/1078-0432.CCR-22-1600","volume":"28","author":"S Paudel","year":"2022","unstructured":"Paudel, S. et al. Serologic profiling using an epstein-barr virus mammalian expression library identifies EBNA1 IgA as a prediagnostic marker for nasopharyngeal carcinoma. Clin. Cancer Res. 28, 5221\u20135230 (2022).","journal-title":"Clin. Cancer Res."},{"key":"948_CR208","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60999-5","volume":"16","author":"MF Ji","year":"2025","unstructured":"Ji, M. F. et al. Epstein Barr virus antibody and cancer risk in two prospective cohorts in Southern China. Nat. Commun. 16, 5940 (2025).","journal-title":"Nat. Commun."},{"key":"948_CR209","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1056\/NEJMoa013215","volume":"347","author":"HI Yang","year":"2002","unstructured":"Yang, H. I. et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N. Engl. J. Med. 347, 168\u2013174 (2002).","journal-title":"N. Engl. J. Med."},{"key":"948_CR210","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1023\/A:1019511224501","volume":"13","author":"K Arisaw","year":"2002","unstructured":"Arisaw, K. et al. A nested case\u2013control study of risk factors for adult T-cell leukemia\/lymphoma among human T-cell lymphotropic virus type-I carriers in Japan. Cancer Causes Control 13, 657\u2013663 (2002).","journal-title":"Cancer Causes Control"},{"key":"948_CR211","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1056\/NEJM199607253350403","volume":"335","author":"SJ Gao","year":"1996","unstructured":"Gao, S. J. et al. Seroconversion to antibodies against Kaposi\u2019s sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi\u2019s sarcoma. N. Engl. J. Med. 335, 233\u2013241 (1996).","journal-title":"N. Engl. J. Med."},{"key":"948_CR212","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/cam4.44","volume":"2","author":"ES Amirian","year":"2013","unstructured":"Amirian, E. S., Marquez-Do, D., Bondy, M. L. & Scheurer, M. E. Anti-human-cytomegalovirus immunoglobulin G levels in glioma risk and prognosis. Cancer Med. 2, 57\u201362 (2013).","journal-title":"Cancer Med."},{"key":"948_CR213","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/ijc.33987","volume":"151","author":"AE Coghill","year":"2022","unstructured":"Coghill, A. E. et al. Prospective investigation of herpesvirus infection and risk of glioma. Int. J. Cancer 151, 222\u2013228 (2022).","journal-title":"Int. J. Cancer"},{"key":"948_CR214","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa1701717","volume":"377","author":"KCA Chan","year":"2017","unstructured":"Chan, K. C. A. et al. Analysis of plasma Epstein-Barr Virus DNA to screen for nasopharyngeal cancer. N. Engl. J. Med. 377, 513\u2013522 (2017). The key clinical translation paper for EBV-based screening for nasopharyngeal cancer.","journal-title":"N. Engl. J. Med."},{"key":"948_CR215","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1093\/jnci\/djaa198","volume":"113","author":"JA Miller","year":"2021","unstructured":"Miller, J. A., Le, Q. T., Pinsky, B. A. & Wang, H. Cost-effectiveness of nasopharyngeal carcinoma screening with Epstein\u2013Barr virus polymerase chain reaction or serology in high-incidence populations worldwide. J. Natl Cancer Inst. 113, 852\u2013862 (2021).","journal-title":"J. Natl Cancer Inst."},{"key":"948_CR216","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","volume":"360","author":"R Sankaranarayanan","year":"2009","unstructured":"Sankaranarayanan, R. et al. HPV screening for cervical cancer in rural India. N. Engl. J. Med. 360, 1385\u20131394 (2009).","journal-title":"N. Engl. J. Med."},{"key":"948_CR217","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1158\/1940-6207.CAPR-13-0091","volume":"6","author":"FH Zhao","year":"2013","unstructured":"Zhao, F. H. et al. An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China. Cancer Prev. Res. 6, 938\u2013948 (2013).","journal-title":"Cancer Prev. Res."},{"key":"948_CR218","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/ijc.28639","volume":"135","author":"E Lazcano-Ponce","year":"2014","unstructured":"Lazcano-Ponce, E. et al. Specimen self-collection and HPV DNA screening in a pilot study of 100,242 women. Int. J. Cancer 135, 109\u2013116 (2014).","journal-title":"Int. J. Cancer"},{"key":"948_CR219","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1038\/s41591-023-02658-0","volume":"29","author":"RV Barnabas","year":"2023","unstructured":"Barnabas, R. V. et al. Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results. Nat. Med. 29, 3224\u20133232 (2023).","journal-title":"Nat. Med."},{"key":"948_CR220","doi-asserted-by":"publisher","first-page":"e02248-","DOI":"10.1128\/mBio.02248-18","volume":"9","author":"GD Hannigan","year":"2018","unstructured":"Hannigan, G. D., Duhaime, M. B., Ruffin, M. T. T., Koumpouras, C. C. & Schloss, P. D. Diagnostic potential and interactive dynamics of the colorectal cancer virome. mBio 9, e02248-18 (2018).","journal-title":"mBio"},{"key":"948_CR221","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/HEP.0000000000001046","volume":"82","author":"CL Hsu","year":"2025","unstructured":"Hsu, C. L. et al. Viral antibody response predicts morbidity and mortality in alcohol-associated hepatitis. Hepatology 82, 127\u2013139 (2025).","journal-title":"Hepatology"},{"key":"948_CR222","doi-asserted-by":"publisher","first-page":"a035774","DOI":"10.1101\/cshperspect.a035774","volume":"13","author":"J Lipsick","year":"2021","unstructured":"Lipsick, J. A history of cancer research: tumor viruses. Cold Spring Harb. Perspect. Biol. 13, a035774 (2021).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"948_CR223","doi-asserted-by":"crossref","unstructured":"Wu, T.-C., Chang, M. H. & Jeang, K.-T. (eds) Viruses and Human Cancer: From Basic Science to Clinical Prevention 2nd edn (Springer, 2021).","DOI":"10.1007\/978-3-030-57362-1"},{"key":"948_CR224","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1084\/jem.13.4.397","volume":"13","author":"P Rous","year":"1911","unstructured":"Rous, P. A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J. Exp. Med. 13, 397\u2013411 (1911). The foundational study for the field of tumour virology, demonstrating that a filterable agent \u2014 later identified as a retrovirus \u2014 could transmit sarcoma between chickens.","journal-title":"J. Exp. Med."},{"key":"948_CR225","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1158\/0008-5472.CAN-08-3301","volume":"68","author":"RT Javier","year":"2008","unstructured":"Javier, R. T. & Butel, J. S. The history of tumor virology. Cancer Res. 68, 7693\u20137706 (2008).","journal-title":"Cancer Res."},{"key":"948_CR226","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/260170a0","volume":"260","author":"D Stehelin","year":"1976","unstructured":"Stehelin, D., Varmus, H. E., Bishop, J. M. & Vogt, P. K. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260, 170\u2013173 (1976). This study identified normal cellular homologues of the transforming genes that avian sarcoma viruses have, establishing the concept of proto-oncogenes and the connection between virology and cancer cell biology, winning the authors a Nobel Prize.","journal-title":"Nature"},{"key":"948_CR227","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/297474a0","volume":"297","author":"LF Parada","year":"1982","unstructured":"Parada, L. F., Tabin, C. J., Shih, C. & Weinberg, R. A. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus Ras gene. Nature 297, 474\u2013478 (1982).","journal-title":"Nature"},{"key":"948_CR228","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/307521a0","volume":"307","author":"J Downward","year":"1984","unstructured":"Downward, J. et al. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307, 521\u2013527 (1984).","journal-title":"Nature"},{"key":"948_CR229","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0092-8674(81)90263-4","volume":"23","author":"JM Bishop","year":"1981","unstructured":"Bishop, J. M. Enemies within: the genesis of retrovirus oncogenes. Cell 23, 5\u20136 (1981).","journal-title":"Cell"},{"key":"948_CR230","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrc3320","volume":"12","author":"PK Vogt","year":"2012","unstructured":"Vogt, P. K. Retroviral oncogenes: a historical primer. Nat. Rev. Cancer 12, 639\u2013648 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"948_CR231","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1073\/pnas.80.12.3812","volume":"80","author":"M Durst","year":"1983","unstructured":"Durst, M., Gissmann, L., Ikenberg, H. & zur Hausen, H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl Acad. Sci. USA 80, 3812\u20133815 (1983). This study identified HPV DNA in cervical carcinoma and demonstrated its geographical prevalence in cancer biopsies, an experimental breakthrough, which led to Harald zur Hausen being awarded the Nobel Prize and the subsequent development of HPV vaccines.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"948_CR232","doi-asserted-by":"publisher","first-page":"S3\/1","DOI":"10.1016\/j.vaccine.2006.05.115","volume":"24","author":"N Munoz","year":"2006","unstructured":"Munoz, N., Castellsague, X., Berrington de Gonzalez, A. & Gissmann, L. Chapter 1: HPV in the etiology of human cancer. Vaccine 24, S3\/1\u2013S3\/10 (2006).","journal-title":"Vaccine"},{"key":"948_CR233","first-page":"415","volume":"1","author":"KH Vousden","year":"1990","unstructured":"Vousden, K. H. Human papillomavirus oncoproteins. Semin. Cancer Biol. 1, 415\u2013424 (1990).","journal-title":"Semin. Cancer Biol."},{"key":"948_CR234","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/S0966-842X(00)01830-8","volume":"8","author":"A Alcami","year":"2000","unstructured":"Alcami, A. & Koszinowski, U. H. Viral mechanisms of immune evasion. Trends Microbiol. 8, 410\u2013418 (2000).","journal-title":"Trends Microbiol."},{"key":"948_CR235","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1016\/j.cell.2026.02.013","volume":"189","author":"W Qian","year":"2026","unstructured":"Qian, W. et al. Respiratory viral infections prime accelerated lung cancer growth. Cell 189, 2845\u20132856.e20 (2026).","journal-title":"Cell"}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41568-026-00948-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-026-00948-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-026-00948-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:07:49Z","timestamp":1787573269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41568-026-00948-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":235,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["948"],"URL":"https:\/\/doi.org\/10.1038\/s41568-026-00948-6","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"21 May 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}